David Dalvey - 19 May 2025 Form 4 Insider Report for Celcuity Inc. (CELC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 May 2025, 16:49:35 UTC
Prior SEC filing
06 Jun 2024
Next SEC filing
30 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Griffin D. Foster, as Attorney-in-Fact for David F. Dalvey pursuant to Power of Attorney attached hereto

Key filing fact

David Dalvey filed Form 4 for Celcuity Inc. (CELC) on 21 May 2025.

Key facts

  • This page summarizes David Dalvey's Form 4 filing for Celcuity Inc. (CELC).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 21 May 2025, 16:49.

Change

  • Previous filing in this sequence was filed on 06 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001296457 Primary reporting owner

Dalvey David

Relationship
Director
Address
16305 36TH AVENUE NORTH, SUITE 100, MINNEAPOLIS
Signature
/s/ Griffin D. Foster, as Attorney-in-Fact for David F. Dalvey pursuant to Power of Attorney attached hereto
Signature date
21 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CELC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+14,048
Change %
Price
$0.000000
Shares after
14,048
Date
19 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,048
Exercise price
$10.69
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Option will vest and become exercisable on April 30, 2026, or if earlier, the date of the Company's 2026 Annual Meeting of Stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .